STERIS plc $STE Shares Sold by Generation Investment Management LLP

Generation Investment Management LLP lowered its stake in shares of STERIS plc (NYSE:STE) by 5.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,984,939 shares of the medical equipment provider’s stock after selling 185,778 shares during the period. STERIS comprises 4.9% of Generation Investment Management LLP’s portfolio, making the stock its 8th largest holding. Generation Investment Management LLP owned 3.03% of STERIS worth $738,593,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Steigerwald Gordon & Koch Inc. acquired a new stake in shares of STERIS during the 3rd quarter valued at approximately $25,000. Spurstone Advisory Services LLC acquired a new stake in shares of STERIS in the 2nd quarter worth approximately $29,000. Cloud Capital Management LLC purchased a new position in STERIS in the 3rd quarter valued at approximately $29,000. Geneos Wealth Management Inc. raised its holdings in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 104 shares during the last quarter. Finally, TruNorth Capital Management LLC acquired a new position in STERIS during the third quarter worth $37,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Price Performance

Shares of NYSE:STE opened at $246.97 on Tuesday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The business’s fifty day moving average price is $255.96 and its two-hundred day moving average price is $251.56. The stock has a market cap of $24.22 billion, a PE ratio of 34.45 and a beta of 1.03. STERIS plc has a one year low of $204.90 and a one year high of $269.44.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same period in the previous year, the business earned $2.32 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Tuesday, February 17th. STERIS’s dividend payout ratio is 35.15%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on STE. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Wall Street Zen downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, STERIS has an average rating of “Moderate Buy” and an average price target of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.